Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 474 of 1,261

  1. US 10414740

    Glutaminase inhibitors and method of use

    Agios Pharmaceuticals, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  2. US 10414761

    Cyclopropanamine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  3. US 10414732

    Polymorphic compounds and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  4. US 10414725

    Pyrrolomycins and methods of using the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  5. US 10413620

    Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  6. US 10413603

    Compositions, methods and uses for improved human papilloma virus constructs

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  7. US 10413580

    Compositions comprising Cyclocarya paliurus extract and preparation method and uses thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  8. US 10406249

    Gd(III)-dithiolane gold nanoparticle conjugates

    Northwestern University · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  9. US 10407678

    Compositions for modulating expression of C9ORF72 antisense transcript

    Ionis Pharmaceuticals, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  10. US 10407503

    Fully human antibodies and fragments recognizing human c-Met

    The Regents of the University of California · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  11. US 10407495

    Bispecific antibody fragments for neurological disease proteins and methods of use

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  12. US 10407488

    Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation

    The Regents of the University of California · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  13. US 10407485

    Murine anti-NY-ESO-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  14. US 10407508

    Compositions and methods for increasing protein half-life in a serum

    Nanjing Legend Biotech Co., Ltd · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  15. US 10407468

    Methods for synthesizing α4β7 peptide antagonists

    Protagonist Therapeutics, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  16. US 10407445

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  17. US 10407476

    Methods and compositions for treating hemophilia

    Sangamo Therapeutics, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  18. US 10407457

    Pyrrolopyrimidine nucleosides and analogs thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  19. US 10407414

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  20. US 10407403

    Preparation method of cobimetinib

    Suzhou Miracpharma Technology Co., Ltd. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  21. US 10407405

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  22. US 10407416

    Kappa opioid agonists and uses thereof

    Nektar Therapeutics · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  23. US 10407374

    Compositions and methods for ameliorating CNS inflammation, psychosis, delirium, PTSD or PTSS

    The Regents of the University of California · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  24. US 10406385

    Photoluminescent panthenol citrate biomaterials

    Northwestern University · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.